[lcus_masonry_article] Case Study: A Pharma Partner Licenses the Parkinson’s Cure Discovery Package for Pipeline A pharmaceutical company with a strong CNS pipeline was looking for a cure-focused Parkinson’s asset—not another symptomatic therapy—that came with a clear discovery report, methodology, compound analysis, and synthesis pathways. They had the development and regulatory capacity; they needed a defined […]
content by LCUS
Product Insight – Cure-Focused vs Symptom-Focused, What to Ask When the Goal Is Disease Modification
[lcus_masonry_article] Product Insight: Cure-Focused vs Symptom-Focused—What to Ask When the Goal Is Disease Modification Parkinson’s care has long been dominated by symptom management. The Parkinson’s Cure Discovery product is built around a different goal: compounds and mechanisms capable of curing or fundamentally modifying the disease. The product insight is how to evaluate it: you are […]